U.S. Markets open in 15 hrs, 35 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 34.42 09:35 AM EST | |
|---|---|---|
| Day High | 35.49 03:30 PM EST |
|
| Range | 1.07 |
| Volume | 1.12 M | |
|---|---|---|
| 30-Day Avg Vol | 1.17 M |
|
| Difference | -4.54% |
| Market Cap | 3.73 B | |
|---|---|---|
| Mkt Cap Chg | 57.09 M |
| Shares Out | 105.72 M | |
|---|---|---|
| % Shrs Traded | 1.06% | |
| 1yr EPS Est | 2.675 |
| 52-Wk Low | 20.19 | |
|---|---|---|
| 52-Wk High | 38.48 |
|
| Range | 18.29 |
| Prev Close | 34.83 11/5/09 | |
|---|---|---|
| Today's Open | 34.75 | |
| Change | -0.23% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 5.62 M |
| Revenue (LFY) | 2.53 B | |
|---|---|---|
| Earnings (LFY) | 238.38 M | |
| Earnings (MRQ) | 63.00 M | |
| Next Earn Est | 0.713 | |
| Next Earnings | 02/17/2010 |
|
| EPS (TTM) | 1.95 | |
| 1yr EPS Growth | 12.40% |
| P/E Ratio (TTM) | 14.50 | |
|---|---|---|
| P/E Ratio (Fwd) | 13.00 | |
| PEG Ratio | 1.15 | |
| Return on Equity | 10.35 | |
| Beta | 0.59 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Watson Pharmaceuticals tries to have the best of both worlds, with operations in the US generics market and the higher-profit-margin branded drug business. The company's broad generics portfolio of about ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.713 2/17/10 | — — |
—
—
|
| Last Quarter | 0.646 9/30/09 | 0.66 9/30/09 |
0.014
Beat
|
| 2 Quarters Ago | 0.572 6/30/09 | 0.61 6/30/09 |
0.038
Beat
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 662.10 M | 2.54 B |
| Gross Profit | 286.20 M | 980.04 M |
| Operating Income | 114.20 M | 388.88 M |
| Net Income | 63.00 M | 238.38 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts